These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32005658)

  • 1. Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease.
    Zhong X; Jagarlapudi S; Weng Y; Ly M; Rouse JC; McClure K; Ishino T; Zhang Y; Sousa E; Cohen J; Tzvetkova B; Cote K; Scarcelli JJ; Johnson K; Palandra J; Apgar JR; Yaddanapudi S; Gonzalez-Villalobos RA; Opsahl AC; Lam K; Yao Q; Duan W; Sievers A; Zhou J; Ferguson D; D'Antona A; Zollner R; Zhu HL; Kriz R; Lin L; Clerin V
    J Biol Chem; 2020 Mar; 295(10):3115-3133. PubMed ID: 32005658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble klotho regulates TRPC6 calcium signaling
    Wright JD; An SW; Xie J; Lim C; Huang CL
    FASEB J; 2019 Aug; 33(8):9182-9193. PubMed ID: 31063704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent.
    Erben RG
    Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):229-235. PubMed ID: 29851418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeled structural basis for the recognition of α2-3-sialyllactose by soluble Klotho.
    Wright JD; An SW; Xie J; Yoon J; Nischan N; Kohler JJ; Oliver N; Lim C; Huang CL
    FASEB J; 2017 Aug; 31(8):3574-3586. PubMed ID: 28442546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease-Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows.
    Martín-Vírgala J; Martín-Carro B; Fernández-Villabrille S; Ruiz-Torres MP; Gómez-Alonso C; Rodríguez-García M; Fernández-Martín JL; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment.
    Martín-Vírgala J; Fernández-Villabrille S; Martín-Carro B; Tamargo-Gómez I; Navarro-González JF; Mora-Fernández C; Calleros L; Astudillo-Cortés E; Avello-Llano N; Mariño G; Dusso AS; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble αKlotho as a candidate for the biomarker of aging.
    Koyama D; Sato Y; Aizawa M; Maki T; Kurosawa M; Kuro-o M; Furukawa Y
    Biochem Biophys Res Commun; 2015 Nov; 467(4):1019-25. PubMed ID: 26462468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klotho is upregulated in human cardiomyopathy independently of circulating Klotho levels.
    Poelzl G; Ghadge SK; Messner M; Haubner B; Wuertinger P; Griesmacher A; Doerler J; Ensinger C; Ulmer H; Zaruba MM
    Sci Rep; 2018 May; 8(1):8429. PubMed ID: 29849175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
    Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active vitamin D is cardioprotective in experimental uraemia but not in children with CKD Stages 3-5.
    Schön A; Leifheit-Nestler M; Deppe J; Fischer DC; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Yilmaz A; Mir S; Yalcinkaya F; Soylemezoglu O; Melk A; Stangl GI; Behnisch R; Shroff R; Bacchetta J; Querfeld U; Schaefer F; Haffner D;
    Nephrol Dial Transplant; 2021 Feb; 36(3):442-451. PubMed ID: 33241290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic Regulation of Systemic Klotho Levels by Renal CaSR Signaling in Response to CaSR Ligands and pH o.
    Yoon J; Liu Z; Lee E; Liu L; Ferre S; Pastor J; Zhang J; Moe OW; Chang AN; Miller RT
    J Am Soc Nephrol; 2021 Dec; 32(12):3051-3065. PubMed ID: 34551996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor γ reduces the progression of chronic kidney disease.
    Lin W; Zhang Q; Liu L; Yin S; Liu Z; Cao W
    Kidney Int; 2017 Sep; 92(3):669-679. PubMed ID: 28416226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between Soluble
    Wang Q; Su W; Shen Z; Wang R
    Biomed Res Int; 2018; 2018():9481475. PubMed ID: 30159331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone and Klotho.
    Schmid C; Neidert MC; Tschopp O; Sze L; Bernays RL
    J Endocrinol; 2013 Nov; 219(2):R37-57. PubMed ID: 24096965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children.
    Kunert SK; Hartmann H; Haffner D; Leifheit-Nestler M
    J Bone Miner Metab; 2017 Mar; 35(2):215-226. PubMed ID: 27017221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFβ-incurred epigenetic aberrations of miRNA and DNA methyltransferase suppress Klotho and potentiate renal fibrosis.
    Yin S; Zhang Q; Yang J; Lin W; Li Y; Chen F; Cao W
    Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1207-1216. PubMed ID: 28285987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Klotho Protein in Chronic Kidney Disease: Studies in Animals and Humans.
    Gołembiewska E; Stępniewska J; Kabat-Koperska J; Kędzierska K; Domański M; Ciechanowski K
    Curr Protein Pept Sci; 2016; 17(8):821-826. PubMed ID: 27226196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.
    Seiler S; Rogacev KS; Roth HJ; Shafein P; Emrich I; Neuhaus S; Floege J; Fliser D; Heine GH
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1049-58. PubMed ID: 24677555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. αKlotho-FGF23 interactions and their role in kidney disease: a molecular insight.
    Smith ER; Holt SG; Hewitson TD
    Cell Mol Life Sci; 2019 Dec; 76(23):4705-4724. PubMed ID: 31350618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
    Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.